News, Transactions, and Industry Insights
News and analysis from PharmaBioSource: announcements of closed transactions, commentary on pharma and biotech deal activity, and operator-level views on the trends shaping life sciences M&A, real estate, diligence, and licensing. All content is written by senior advisors with operating experience in the asset classes we cover.
PharmaBioSource Realty Represents SHL Medical in the U.S.
PharmaBioSource Realty represented SHL Medical (www.shl-medical.com) on the lease of its new U.S. medical device injection molding manufacturing facility in Charleston, SC. The facility totals 270,000 SF of space and SHL is planning a $90M investment over the next 2 years. Once operational in 2024, SHL will employ 165 staff to support its growing autoinjector […]